Risk factor
Poor trading liquidity
Profitability factor
Excellent dividends
About
PT Industri Jamu dan Farmasi Sido Muncul Tbk provides herbal medicines, cosmetics, and foods and beverages related to health in Indonesia. It operates through Herbal Medicine and Supplements, Food and Beverage, and Pharmacy segments. The company offers ethical and OTC products for various health interests, including ache and pain relief, antibiotics, anemia, anti-allergy, antioxidants, blood pressure, brain function, bone health, children's health, cold, flu, and cough, as well as diabetes, digestion, energy and vitality, heart and cholesterol, immune system, joints and mobility, liver and detox, men's health, skin health, sleep aids, tumor and cancer, weight management, women's health, and others. In addition, it is also involved in commerce, land transportation, wastewater treatment, and plantation and printing activities. The company was founded in 1940 and is headquartered in Semarang, Indonesia. PT Industri Jamu dan Farmasi Sido Muncul Tbk is a subsidiary of PT Hotel Candi Baru.
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV
Target Price
The average target price of SIDO.JK is 606 and suggests 22% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
Buy
Sell